NEW YORK(GenomeWeb) – Sample prep firm Ceres Nanosciences said yesterday that it has received $746,000 in funding from the Bill & Melinda Gates Foundation to develop a urine-based tuberculosis test.

The test, which is aimed at diagnosing active pulmonary tuberculosis, will use Ceres' Nanotrap reagents, hydrogel nanoparticles functionalized with internal affinity baits to enrich target analytes for downstream analysis.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.